Herein, we report a case of BRAF V600E mutation in only one of the multiple intrapulmonary metastatic lesions during treatment with osimertinib for patients with lung adenocarcinoma with EGFR exon 19 deletion. The gene discussed is EGFR; the disease is lung adenocarcinoma.